Airway diseases
Oral presentation
Paediatric asthma: important novel insights into mechanism, diagnosis and management
Clinical
Translational
Methods :
Cell and molecular biology, Epidemiology, General respiratory patient care, Pulmonary function testing, Physiology, Imaging
11:00
Late Breaking Abstract - Vitamin D In the prevention of Viral-induced Asthma (DIVA) in preschoolers: a randomised controlled trial
F. Ducharme(Montréal (QC), Canada)
COI
1
OA1258
11:05
Distinct Metabolomic and Lipidomic Signatures in Obese and Normal-Weight Children with Asthma
H. Shailesh(Doha, Qatar)
COI
2
OA1260
11:10
Maternal obesity and offspring allergic disease:implications of impaired barrier function
N. Ubags(Epalinges, Switzerland)
COI
3
OA1261
11:15
Impact of PM2.5 Exposure Trajectories on Asthma and Airway Hyperresponsiveness in Children through S100 protein expression: The COCOA Study
S. YANG(Anyang, Republic of Korea)
COI
4
OA1262
11:20
What is the role of fractional exhaled nitric oxide in the diagnosis of school-age asthma?
M. Sasaki(Bern, Switzerland)
COI
5
OA1263
11:25
Asthma Diagnostic Pathway: FeNO as a first-line diagnostic tool
A. Lana(Leicester, United Kingdom)
COI
6
OA1264
11:30
Association of early-life dust allergens and endotoxin with childhood asthma and lung function: An analysis of the CHILD study
J. McCoy(Toronto, Canada)
COI
7
OA1265
11:35
Automatic detection of mucus plugs on computed tomography scans in severe paediatric asthma
W. van den Bosch(Voorburg, Netherlands)
COI
8
OA1266
11:40
Abnormal LCI 2.5% measurement early in life of children with wheeze and asthma is associated with impaired lung function development
N. Jakobs(Lübeck, Germany)
COI
9
OA1267
11:45
Telemedicine-enabled home monitoring enhances asthma control in children: A randomized controlled trial
P. Stafler(Ra'anana, Israel)
COI
10
OA1268
11:50
Discussion and Q&A
11
OA1259
. . .
